Thursday, June 2, 2016

BRIEF-Onxeo announces development of Beleodaq Oral formulation

* Onxeo announces development of Beleodaq Oral formulation opening new opportunities for its

HDAC inhibitor

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)